AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15780537 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 26
Study 11975863 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA (300 mg)
Number of subjects: 16
Study 11975863 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 11975863 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA and Placebo
Number of subjects: 16
Study 10188125 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereolithographic biomodelling (biomodels)
Number of subjects: 45
Study 8554932 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg salbutamol via nebuliser
Number of subjects: 8
Study 8554932 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 1824806 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin (mean dose 4.35 ± 0.2 mg/day)
Number of subjects: 17
Study 1824806 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 17
Study 6620532 — intervention group
Group type: COMPARATOR
Intervention: Group C (no premedication)
Number of subjects: 63
Study 6620532 — intervention group
Group type: EXPERIMENTAL
Intervention: Group D (diazepam 0.2mg/kg i.m.)
Number of subjects: 63
Study 6620532 — intervention group
Group type: EXPERIMENTAL
Intervention: Group M (meperidine 1mg/kg i.m.)
Number of subjects: 63
Study 6620532 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (atropine 0.01mg/kg i.m.)
Number of subjects: 63
Study 6620532 — intervention group
Group type: EXPERIMENTAL
Intervention: Group AD (atropine 0.01mg/kg and diazepam 0.2mg/kg i.m.)
Number of subjects: 63
Study 6620532 — intervention group
Group type: EXPERIMENTAL
Intervention: Group AM (atropine 0.01mg/kg and meperidine 1mg/kg i.m.)
Number of subjects: 63
Study 31072841 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise therapy plus early reconstructive surgery
Number of subjects: 100
Study 31072841 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise therapy plus delayed reconstructive surgery, if needed
Number of subjects: 100
Study 29768643 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) - Full squat with low-load (45-60% 1RM) and low-volume (2-3 sets and 4-6 repetitions)
Number of subjects: 34
Study 29768643 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Resistance Training and Loaded Change of Direction (S+CDG) - Same RT program combined with loaded CD (2-5 sets of 10 s)
Number of subjects: 34
Study 29768643 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 34
Study 26411271 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardio neuroablation (CNA) via radiofrequency catheter ablation (RFCA) targeting the three main paracardiac ganglia around the heart.
Number of subjects: 22
Study 26411271 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardio neuroablation (CNA) via RFCA targeting the three main paracardiac ganglia around the heart.
Number of subjects: 22
Study 26411271 — intervention group
Group type: COMPARATOR
Intervention: Atropine infusion on admission.
Number of subjects: 22
Study 23269469 — intervention group
Group type: EXPERIMENTAL
Intervention: Acoustical measures
Number of subjects: 89
Study 23269469 — intervention group
Group type: EXPERIMENTAL
Intervention: Organizational measures
Number of subjects: 89
Study 23269469 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 89
Study 22335998 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance training
Number of subjects: 18
Study 22335998 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight training
Number of subjects: 18
Study 22335998 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 18
Study 20635236 — intervention group
Group type: EXPERIMENTAL
Intervention: 40-min live group music programme, three times a week for eight weeks
Number of subjects: 47
Study 20635236 — intervention group
Group type: COMPARATOR
Intervention: Reading control group
Number of subjects: 47
Study 17257444 — intervention group
Group type: EXPERIMENTAL
Intervention: ICU-based medical emergency team (MET) service
Number of subjects: 2183
Study 17257444 — intervention group
Group type: COMPARATOR
Intervention: Control period (no MET)
Number of subjects: 2183
Study 16380589 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral amiodarone (10 mg/kg daily) administered 6 days prior to surgery through 6 days after surgery (13 days)
Number of subjects: 601
Study 16380589 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 601
Study 16380589 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral amiodarone
Number of subjects: 601
Study 12216049 — intervention group
Group type: EXPERIMENTAL
Intervention: Levalbuterol
Number of subjects: 147
Study 11475741 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial Shexiang Baoxin Pill (SXBXP)
Number of subjects: 225
Study 11475741 — intervention group
Group type: COMPARATOR
Intervention: Natural Shexiang Baoxin Pill (SXBXP)
Number of subjects: 225
Study 7649426 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with family history of thrombosis
Number of subjects: 73
Study 7649426 — intervention group
Group type: COMPARATOR
Intervention: Patients with family history of MI
Number of subjects: 73
Study 7649426 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole population of MI patients
Number of subjects: 73
Study 2668784 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine (AZ) with methylprednisolone (MP) for the first 36 weeks
Number of subjects: 98
Study 2668784 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine (AZ)
Number of subjects: 98
Study 2668784 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine (AZ) with methylprednisolone (MP)
Number of subjects: 98
Study 2668784 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for both drugs)
Number of subjects: 98
Study 711895 — intervention group
Group type: EXPERIMENTAL
Intervention: Marihuana in a threat environment
Number of subjects: 60
Study 711895 — intervention group
Group type: EXPERIMENTAL
Intervention: Marihuana in a no-threat environment
Number of subjects: 60
Study 711895 — intervention group
Group type: COMPARATOR
Intervention: Placebo in a threat environment
Number of subjects: 60
Study 711895 — intervention group
Group type: COMPARATOR
Intervention: Placebo in a no-threat environment
Number of subjects: 60
Study 31845535 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental Shuttle Walk Test (ISWT)
Number of subjects: 40
Study 31845535 — intervention group
Group type: EXPERIMENTAL
Intervention: Timed Up and Go (TUAG)
Number of subjects: 40
Study 31845535 — intervention group
Group type: EXPERIMENTAL
Intervention: Sit-to-Stand Transfers in 60 seconds (STS-60)
Number of subjects: 40
Study 31845535 — intervention group
Group type: EXPERIMENTAL
Intervention: Duke's Activity Status Index (DASI)
Number of subjects: 40
Study 31845535 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital Anxiety and Depression Scale (HAD) - Anxiety Subscale
Number of subjects: 40
Study 31845535 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital Anxiety and Depression Scale (HAD) - Depression Subscale
Number of subjects: 40
Study 29236554 — intervention group
Group type: EXPERIMENTAL
Intervention: Vicarious Self-Affirmation (VSA) condition
Number of subjects: 225
Study 29236554 — intervention group
Group type: COMPARATOR
Intervention: Vicarious Control condition
Number of subjects: 225
Study 29236554 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional value affirmation
Number of subjects: 225
Study 28816728 — intervention group
Group type: EXPERIMENTAL
Intervention: OPTI‐FREE PureMoist with ETA lenses
Number of subjects: 791
Study 28816728 — intervention group
Group type: COMPARATOR
Intervention: ETA lenses
Number of subjects: 791
Study 28816728 — intervention group
Group type: COMPARATOR
Intervention: SENO lenses
Number of subjects: 791
Study 28816728 — intervention group
Group type: COMPARATOR
Intervention: GALY lenses
Number of subjects: 791
Study 28816728 — intervention group
Group type: COMPARATOR
Intervention: All lens types with any of the four care solutions
Number of subjects: 791
Study 26005839 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 223
Study 26005839 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 223
Study 26005839 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) in Veterans
Number of subjects: 223
Study 23670850 — intervention group
Group type: EXPERIMENTAL
Intervention: At-risk overweight/obese (ARO) women
Number of subjects: 0
Study 23670850 — intervention group
Group type: COMPARATOR
Intervention: Metabolically benign overweight/obese (MBO) women
Number of subjects: 0
Study 21375950 — intervention group
Group type: EXPERIMENTAL
Intervention: First donning experience of life jackets
Number of subjects: 56
Study 21375950 — intervention group
Group type: COMPARATOR
Intervention: Subsequent donning experiences of life jackets
Number of subjects: 56
Study 18191265 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant chemo radiation treatment
Number of subjects: 119
Study 16314075 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical anesthesia
Number of subjects: 20
Study 16314075 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 16314075 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical anesthesia first
Number of subjects: 20
Study 16314075 — intervention group
Group type: COMPARATOR
Intervention: Placebo first
Number of subjects: 20
Study 12637115 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg
Number of subjects: 1087
Study 12637115 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin 20 mg
Number of subjects: 1087
Study 10850611 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate Mofetil (MMF)
Number of subjects: 57
Study 10850611 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine (AZA)
Number of subjects: 57
Study 9093249 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcervical resection of the endometrium (TCRE)
Number of subjects: 202
Study 9093249 — intervention group
Group type: COMPARATOR
Intervention: Hysterectomy
Number of subjects: 202
Study 7681769 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic porcine galanin IV, 500 micrograms in 100 mL
Number of subjects: 5
Study 7681769 — intervention group
Group type: COMPARATOR
Intervention: Saline IV, 100 mL
Number of subjects: 5
Study 3486264 — intervention group
Group type: EXPERIMENTAL
Intervention: Human surfactant treatment
Number of subjects: 0
Study 3486264 — intervention group
Group type: COMPARATOR
Intervention: Conventional mechanical ventilation
Number of subjects: 0
Study 31495382 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard dose of alcohol (one standard drink)
Number of subjects: 115
Study 31495382 — intervention group
Group type: EXPERIMENTAL
Intervention: g/kg dosing of alcohol (controlling for gender)
Number of subjects: 115
Study 31495382 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 115
Study 30047784 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive psychosocial intervention
Number of subjects: 270
Study 30047784 — intervention group
Group type: COMPARATOR
Intervention: Brief psychoeducation with collaborative care
Number of subjects: 270
Study 26608256 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide (1.8 mg daily)
Number of subjects: 52
Study 26608256 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 24992552 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) nasal aerosol at 320 μg once daily
Number of subjects: 529
Study 24992552 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 529
Study 23091097 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorambucil or fludarabine with and without cyclophosphamide
Number of subjects: 224
Study 20506228 — intervention group
Group type: EXPERIMENTAL
Intervention: TR band
Number of subjects: 790
Study 20506228 — intervention group
Group type: COMPARATOR
Intervention: Radistop
Number of subjects: 790
Study 20506228 — intervention group
Group type: EXPERIMENTAL
Intervention: Both devices
Number of subjects: 790
Study 18548866 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15741004 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 38
Study 15741004 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 38
Study 15741004 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 38
Study 15741004 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments (Amitriptyline and Fluvoxamine)
Number of subjects: 38
Study 12747810 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine 20 mg per day
Number of subjects: 15
Study 12747810 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 10561206 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose chemotherapy (doxorubicin 20 mg/m(2), vincristine 1 mg/m(2) on day 1; cyclophosphamide 300 mg/m(2); methotrexate 25 mg/m(2); fluorouracil 600 mg/m(2) on days 29 and 36) plus tamoxifen 20 mg orally for 2 years
Number of subjects: 613
Study 10561206 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen 20 mg orally for 2 years
Number of subjects: 613
Study 10561206 — intervention group
Group type: COMPARATOR
Intervention: No treatment (terminated group)
Number of subjects: 613
Study 8568142 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin prick tests
Number of subjects: 183
Study 8568142 — intervention group
Group type: EXPERIMENTAL
Intervention: Patch tests
Number of subjects: 183
Study 8568142 — intervention group
Group type: COMPARATOR
Intervention: Oral cow milk challenges
Number of subjects: 183
Study 1990041 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefaclor
Number of subjects: 93
Study 1990041 — intervention group
Group type: COMPARATOR
Intervention: Penicillin
Number of subjects: 93
Study 6885683 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxycillin 3g bd
Number of subjects: 207
Study 6885683 — intervention group
Group type: COMPARATOR
Intervention: Amoxycillin 250 mg tds
Number of subjects: 207
Study 31962329 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional medicine-based diet and lifestyle recommendations for at least 3 months
Number of subjects: 180
Study 31962329 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional medicine-based diet and lifestyle recommendations
Number of subjects: 180
Study 31282333 — intervention group
Group type: EXPERIMENTAL
Intervention: Left nostril (Group A)
Number of subjects: 120
Study 31282333 — intervention group
Group type: COMPARATOR
Intervention: Right nostril (Group B)
Number of subjects: 120
Study 28300045 — intervention group
Group type: EXPERIMENTAL
Intervention: Triphala churna
Number of subjects: 60
Study 28300045 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate
Number of subjects: 60
Study 28300045 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 60
Study 25572874 — intervention group
Group type: EXPERIMENTAL
Intervention: Microfluidic device (n = 58)
Number of subjects: 118
Study 25572874 — intervention group
Group type: COMPARATOR
Intervention: Standard microdrop dish (n = 60)
Number of subjects: 118
Study 23487543 — intervention group
Group type: EXPERIMENTAL
Intervention: Response criteria based on NYHA class reduction ≥ 1
Number of subjects: 97
Study 23487543 — intervention group
Group type: EXPERIMENTAL
Intervention: Response criteria based on reduction in left ventricular end‐systolic index by > 15%
Number of subjects: 97
Study 23487543 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical response criteria
Number of subjects: 97
Study 23487543 — intervention group
Group type: EXPERIMENTAL
Intervention: Echocardiographic response criteria
Number of subjects: 97
Study 21656526 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive distal gastrectomy (MIDG)
Number of subjects: 666
Study 21656526 — intervention group
Group type: COMPARATOR
Intervention: Open distal gastrectomy (ODG)
Number of subjects: 666
Study 19293290 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal Management Training
Number of subjects: 34
Study 19293290 — intervention group
Group type: EXPERIMENTAL
Intervention: Identity Oriented Goal Training
Number of subjects: 34
Study 19293290 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 34
Study 17436179 — intervention group
Group type: EXPERIMENTAL
Intervention: In-home exercise program
Number of subjects: 10
Study 17436179 — intervention group
Group type: EXPERIMENTAL
Intervention: Inpatient exercise program
Number of subjects: 10
Study 15603060 — intervention group
Group type: EXPERIMENTAL
Intervention: Young template representing the pigment O‐beta‐glucoside of 3‐hydroxykynurenine in young eyes.
Number of subjects: 0
Study 15603060 — intervention group
Group type: EXPERIMENTAL
Intervention: Aged template representing pigments accumulating in the lens with age.
Number of subjects: 0
Study 15603060 — intervention group
Group type: EXPERIMENTAL
Intervention: Analysis of reflectance spectra in pseudophakes.
Number of subjects: 0
Study 15603060 — intervention group
Group type: EXPERIMENTAL
Intervention: Age effects on photoreceptor reflectivity.
Number of subjects: 0
Study 11687542 — intervention group
Group type: EXPERIMENTAL
Intervention: Latanoprost (0.005%, 30 microl)
Number of subjects: 0
Study 11687542 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0
Study 11687542 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (5 mg/kg) pretreatment
Number of subjects: 0
Study 9149075 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal voluntary isometric contraction (MVIC) testing
Number of subjects: 0
Study 9149075 — intervention group
Group type: COMPARATOR
Intervention: Multiple clinical evaluators in a single site
Number of subjects: 0
Study 9149075 — intervention group
Group type: EXPERIMENTAL
Intervention: Rigorous quality assurance standards and monitoring of clinical evaluators
Number of subjects: 0
Study 8190478 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3% ciprofloxacin
Number of subjects: 32
Study 8190478 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3% norfloxacin
Number of subjects: 32
Study 8190478 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3% ofloxacin
Number of subjects: 32
Study 3070369 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (0.2 mg/kg, 3 times p.o. in 12 h intervals starting on the 3rd day of life)
Number of subjects: 19
Study 3070369 — intervention group
Group type: COMPARATOR
Intervention: Control group (22 VLBWI with comparable weight 1250 ± 154 g, gestational age 28.4 ± 1 weeks)
Number of subjects: 19
Study 3070369 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin treatment
Number of subjects: 19
Study 30511107 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous CIK cells transfusion combined with radiochemotherapy
Number of subjects: 89
Study 30511107 — intervention group
Group type: COMPARATOR
Intervention: Radiochemotherapy
Number of subjects: 89
Study 28532866 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates-inspired exercise training (2 times/week, 60 min/session)
Number of subjects: 40
Study 28532866 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 40
Study 26118755 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped care and monitoring of symptoms
Number of subjects: 46
Study 26118755 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 46
Study 22672773 — intervention group
Group type: EXPERIMENTAL
Intervention: VAC(®) therapy
Number of subjects: 10
Study 22672773 — intervention group
Group type: COMPARATOR
Intervention: Sorbalgon(®) therapy
Number of subjects: 10
Study 21584935 — intervention group
Group type: COMPARATOR
Intervention: Propofol alone (Group P)
Number of subjects: 121
Study 21584935 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol-ketamine combination (Group K)
Number of subjects: 121
Study 18077045 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic lactobacilli-containing yogurt
Number of subjects: 15
Study 17257456 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefdinir 300 mg BID for 10 days
Number of subjects: 391
Study 17257456 — intervention group
Group type: COMPARATOR
Intervention: Cephalexin 250 mg QID for 10 days
Number of subjects: 391
Study 17257456 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefdinir
Number of subjects: 391
Study 17257456 — intervention group
Group type: COMPARATOR
Intervention: Cephalexin
Number of subjects: 391
Study 15147939 — intervention group
Group type: EXPERIMENTAL
Intervention: Discrimination of number
Number of subjects: 2
Study 15147939 — intervention group
Group type: COMPARATOR
Intervention: Cumulative surface area representation
Number of subjects: 2
Study 11226644 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV positive patients with burns
Number of subjects: 33
Study 11226644 — intervention group
Group type: COMPARATOR
Intervention: HIV negative controls
Number of subjects: 33
Study 9832481 — intervention group
Group type: EXPERIMENTAL
Intervention: PTCA (n=44)
Number of subjects: 83
Study 9832481 — intervention group
Group type: COMPARATOR
Intervention: no-PTCA (n=39)
Number of subjects: 83
Study 8125554 — intervention group
Group type: EXPERIMENTAL
Intervention: Digitalis
Number of subjects: 10
Study 8125554 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 2911834 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorthalidone
Number of subjects: 551
Study 2911834 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 551
Study 15029134 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with decreased sodium content
Number of subjects: 0
Study 15029134 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic physical exercise
Number of subjects: 0
Study 15029134 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of diet and aerobic exercise
Number of subjects: 0
Study 31648607 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-control (SC)
Number of subjects: 48
Study 31648607 — intervention group
Group type: COMPARATOR
Intervention: Self-control with load (SCL)
Number of subjects: 48
Study 31648607 — intervention group
Group type: COMPARATOR
Intervention: Yoked (YK)
Number of subjects: 48
Study 31648607 — intervention group
Group type: COMPARATOR
Intervention: Yoked with load (YKL)
Number of subjects: 48
Study 30866926 — intervention group
Group type: EXPERIMENTAL
Intervention: Consultation for chronic cough
Number of subjects: 922